Status:
RECRUITING
Usefulness of Post-Operative Radiotherapy in High-grade Cutaneous Squamous Cell Carcinoma: an Observational Study
Lead Sponsor:
Fondazione IRCCS Policlinico San Matteo di Pavia
Conditions:
Cutaneous Squamous Cell Carcinoma (CSCC)
Eligibility:
All Genders
18+ years
Brief Summary
Post-operative radiotherapy (PORT) is currently considered as the second most important therapy to treat high-grade cutaneous squamous cell carcinoma. Nonetheless, only few studies evaluate its impact...
Eligibility Criteria
Inclusion
- diagnosis of high-grade cutaneous squamous cell carcinoma
- patients eligible for post-operative radiotherapy
- minimum follow-up of 24 months
Exclusion
- lack of clinical of histological data
- impossibility of a proper follow-up
- occurrence of intermediate events (i.e., pregnancy)
Key Trial Info
Start Date :
November 17 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2028
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT06879964
Start Date
November 17 2023
End Date
December 1 2028
Last Update
March 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondazione IRCCS Policlinico San Matteo, SC Dermatologia
Pavia, Pavia, Italy, 27100